Update publication information. In this study, plasma metabolomes before and 3 hours after rivaroxaban intake in nonvalvular atrial ûbrillation (NVAF) patients and age/gender-matched controls were analyzed by liquid chromatography coupled with mass spectrometry (LC3MS/MS).